Product Images Ezetimibe And Simvastatin

This is a product description for Ezetimibe and Simvastatin Tablets by AVKARE. Each tablet contains 10 mg ezetimibe, USP and 10 mg simvastatin, USP. The usual dosage instructions should be consulted; these should be in the package insert. The tablets should be stored at temperatures between 20-25°C (68" to 77F). These tablets are dispensed in a tightly closed container. They are manufactured for AVKARE in Pulasid, TN by Amneal Pharmaceuticals of NY, LLC in Brookhaven. The product was revised in January 2022.*

NDC 4229107910 is a prescription medicine called Ezetimibe and Simvastatin Tablets. This medication contains 10 mg of ezetimibe, USP, and 20 mg of simvastatin, USP. Each bottle contains 1,000 tablets, and the usual dosage information can be found in the package insert. The medication should be stored in a controlled room temperature between 20 to 25 degrees Celsius (68" to 77F) and the container should be tightly closed. These tablets were manufactured by Amneal Pharmaceuticals of Y, LLC in Brookhaven, NY for AKARE in Pulaski, TN 38478.*

NDC 42291-080-10 is a prescription medication containing 10 mg of ezetimibe and 40 mg of simvastatin per tablet. This medication is used to reduce cholesterol levels and is packaged with 1,000 tablets per container. The dosage and other important information can be found in the package insert. The medication should be stored at room temperature and kept tightly closed. It is manufactured by Amneal Pharmaceuticals and distributed by AVKARE.*

NDC 42291-081-50 is a prescription drug with 10 mg ezetimibe, USP and 80 mg simvastatin, USP per tablet. The tablets are manufactured by Amneal Pharmaceuticals of NY, LLC, and supplied in a tightly closed container by AVKARE. The usual dosage and storage instructions can be found in the package insert, and the medication should be kept at 20° to 25C (68° to 77°F).*

This appears to be a chart or table showing the occurrence of Major Vascular Events in a clinical trial involving a placebo group and a group receiving a medication called "Extimibersimvastain." The numbers in the table likely represent the number of patients experiencing events over a certain number of years of follow-up. Without more context or detail, it is difficult to provide a more useful description.*